Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Cellular Adaptation I: Introduction and Atrophy01:23

Cellular Adaptation I: Introduction and Atrophy

Cells can adapt to environmental changes to maintain function and avoid injury, a process called cellular adaptation. Adapted cells exist in a reversible intermediate state with changes in size, number, phenotype, metabolism, or function. These responses help cells meet altered physiological or pathological demands; for example, enlargement of breast and uterine tissues during pregnancy. Early adaptations may enhance function, but persistent stress eventually causes tissue damage.Types of...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

4-anilinoquinoline triazines: a novel class of hybrid antimalarial agents.

European journal of medicinal chemistry·2011
Same author

Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.

The Journal of cell biology·2010
Same author

Buffalo hepcidin: characterization of cDNA and study of antimicrobial property.

Veterinary research communications·2010
Same author

High viral load and deregulation of the progesterone receptor signaling pathway: association with hepatitis E-related poor pregnancy outcome.

Journal of hepatology·2010
Same author

Gα13 and Rho mediate endosomal trafficking of CXCR4 into Rab11+ vesicles upon stromal cell-derived factor-1 stimulation.

Journal of immunology (Baltimore, Md. : 1950)·2010
Same author

Dlk1 is necessary for proper skeletal muscle development and regeneration.

PloS one·2010

Related Experiment Video

Updated: May 24, 2026

Myo-mechanical Analysis of Isolated Skeletal Muscle
08:42

Myo-mechanical Analysis of Isolated Skeletal Muscle

Published on: February 22, 2011

TWEAK and TRAF6 regulate skeletal muscle atrophy.

Ashok Kumar1, Shephali Bhatnagar, Pradyut K Paul

  • 1Department of Anatomical Sciences and Neurobiology, University of Louisville School of Medicine, Louisville, KY 40202, USA. ashok.kumar@louisville.edu

Current Opinion in Clinical Nutrition and Metabolic Care
|February 28, 2012
PubMed
Summary

Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and TRAF6 are newly identified regulators of skeletal muscle atrophy. Targeting these proteins may offer future therapies for muscle wasting conditions.

More Related Videos

Freezing Injury in Mouse Masseter Muscle to Establish an Orofacial Muscle Fibrosis Model
06:33

Freezing Injury in Mouse Masseter Muscle to Establish an Orofacial Muscle Fibrosis Model

Published on: December 29, 2023

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
08:35

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

Published on: June 12, 2017

Related Experiment Videos

Last Updated: May 24, 2026

Myo-mechanical Analysis of Isolated Skeletal Muscle
08:42

Myo-mechanical Analysis of Isolated Skeletal Muscle

Published on: February 22, 2011

Freezing Injury in Mouse Masseter Muscle to Establish an Orofacial Muscle Fibrosis Model
06:33

Freezing Injury in Mouse Masseter Muscle to Establish an Orofacial Muscle Fibrosis Model

Published on: December 29, 2023

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
08:35

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

Published on: June 12, 2017

Area of Science:

  • Muscle physiology and molecular biology
  • Cell signaling pathways
  • Disease mechanisms

Background:

  • Proinflammatory cytokines contribute to muscle atrophy in chronic diseases.
  • The role of cytokines in disuse-induced muscle atrophy is emerging.
  • Signaling events triggering catabolic pathways in muscle atrophy require further understanding.

Purpose of the Study:

  • To elucidate the roles of TWEAK and TRAF6 in skeletal muscle atrophy.
  • To discuss the mechanisms of action of TWEAK and TRAF6 in muscle wasting.
  • To review current understanding of these proteins in atrophic conditions.

Main Methods:

  • Review of recent scientific literature on TWEAK, TRAF6, and skeletal muscle atrophy.
  • Analysis of signaling pathways involved in muscle catabolism.
  • Examination of experimental models of muscle wasting.

Main Results:

  • The TWEAK-Fn14 system is identified as a novel inducer of skeletal muscle wasting.
  • Atrophy conditions like denervation and unloading upregulate Fn14, activating TWEAK-mediated proteolytic pathways.
  • TRAF6 expression and activity increase in muscle atrophy models; its ablation prevents atrophy induction.

Conclusions:

  • TWEAK and TRAF6 are novel regulators of skeletal muscle atrophy.
  • These proteins represent potential molecular targets for preventing or treating muscle atrophy.
  • Further research into TWEAK and TRAF6 pathways could lead to new therapeutic strategies.